Latest Bronchopulmonary dysplasia Stories
New funds will support development of an innovative drug to prevent chronic lung disease in premature infants. Rockville, Maryland (PRWEB) December 17, 2014
Clarassance is now Therabron Therapeutics, Inc.
ReportsnReports.com offers Bronchopulmonary Dysplasia - Pipeline Review, H2 2014 and Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H2 2014 new market reports.
Children who are born preterm have an increased risk developing asthma and wheezing disorders during childhood.
A neonatologist at The Children's Hospital of Philadelphia is the senior author of a large new study that found that current non-invasive techniques for respiratory support are less effective than widely assumed, in reducing the incidence of severe lung injury in very premature infants.
Turmeric, a key ingredient in spicy curry dishes, has long been known to have medicinal values.
For Ottawa scientist and neonatologist Dr. Bernard Thébaud, even a major paper that answers five significant questions still doesn't seem quite enough in his determined path to get his laboratory breakthrough into the neonatal intensive care unit (NICU).